Impetigo: A need for new therapies in a world of increasing antimicrobial resistance

Summary What is known and objective Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children. Antibiotics are the first‐line treatment when multiple lesions exist, but with an increasing prevalence of antibiotic‐resistant bacteria the successful management of impetigo in the future is an area of concern. Comment Current treatment options that favour the use of oral antibiotic therapy are increasingly problematic. Widespread use of these agents contributes to antimicrobial resistance and has adverse consequences for individuals and communities. There is a need for new topical antimicrobials and antiseptics as an alternative treatment strategy. What is new and conclusion To successfully treat impetigo into the future and ensure that therapy does not contribute to bacterial resistance, additional research is required to ascertain the usefulness of alternative agents, including new topical antimicrobials and antiseptics. The increase in antimicrobial resistance has led to concerns about the treatment of conditions such as impetigo, a highly contagious bacterial skin infection. In order to address growing concerns about the widespread use of antimicrobials and the potential for detrimental effects on individuals and communities, new research is required to investigate the long term efficacy and suitability of antimicrobial agents used to treat impetigo and to assess the usefulness of alternative agents such as topical antiseptics.